United Kingdom
Investor relations
980 Great West Road
Brentford
Middlesex TW8 9GS
Tel: +44 (0)20 8047 5557 / 5558
Fax: +44 (0)20 8047 7807
Registrar
Lloyds TSB Registrars
The Causeway
Worthing
West Sussex BN99 6DA
www.shareview.co.uk
General enquiries, Annual Report orderline and Corporate Nominee service
Tel: 0870 600 3991 inside the UK
Tel: +44 (0)121 415 7067 outside the UK
Shareholder Investment Plans
Dividend re-investment enquiries
Tel: 0870 241 3018 inside the UK
Tel: +44 (0)121 415 7067 outside the UK - Ordinary holders
Tel: +44 (0)121 415 7146 outside the UK - Employees
Monthly Savings Plan enquiries
Tel: 0870 606 0268 inside the UK
Tel: +44 (0)131 527 3746 outside the UK
ISA enquiries
Tel: 0870 242 4244 inside the UK
Tel: +44 (0)190 385 4062 outside the UK
Glaxo Wellcome and SmithKline Beecham corporate PEPs
The Share Centre Limited
Oxford House
Oxford Road
Aylesbury
Bucks HP21 8SZ
Tel: +44 (0)129 641 4144
Corporate share dealing facility
Smith Barney
Attention: GSK Services
Citigroup Centre, Level 20
Canada Square, Canary Wharf
London E14 5LB
Tel: +44 (0)20 7508 1795
Fax: +44 (0)20 7890 7281
Email: TheBalaesGroup@Citigroup.com |
|
United States of America
Investor relations
One Franklin Plaza
PO Box 7929 Philadelphia PA 19101
Tel: 1 888 825 5249 toll free
Tel: +1 215 751 7003 outside the US
Fax: +1 215 751 3233
ADR programme administrator
The Bank of New York
Shareholder Relations
PO Box 11258
Church Street Station
New York NY 10286-1258
www.adrbny.com
Tel: 1 877 353 1154 toll free
Tel: +1 610 382 7836 outside the US
Customer Response Center
Tel: 1 888 825 5249 toll free
Corporate share dealing facility
Smith Barney
Attention: GSK Services
53 State Street
39th Floor
Boston
MA 02109
Tel: 1 800 347 6179 toll free
Tel: +1 617 589 3341 outside the US
Fax: +1 617 589 3474
Email: TheTaylorGroup@SmithBarney.com
Our Reports
ANNUAL REVIEW
A review of major communication themes for 2004 and an abridged version of the financial results.
ANNUAL REPORT
The full Financial statements for the year ended 31 December 2004.
Brand names appearing in italics throughout this publication are trademarks either owned by and/or licensed to GSK or associated companies, with the exception of Boniva/Bonviva, a trademark of Roche, and Entereg, a trademark of Adolor Corporation, both of which are used under licence by the Group. |